A systematic review and meta-analysis of the role of Helicobacter pylori eradication in preventing gastric cancer

Background Increasing evidence has suggested that Helicobacter pylori (H. pylori) eradication might prevent the development of gastric cancer (GC). Th is systematic review and meta-analysis aimed to better explore the role of H. pylori eradication in preventing GC, with particular reference to patients with precancerous lesions at baseline histology. Methods Searches for human studies were performed through October 2016 and risk ratios (RRs), were obtained. Heterogeneity between studies was estimated using the Cochran Q test and I 2 values, whereas the possibility of publication bias was estimated with funnel plots. Additionally, we performed subgroup and sensitivity analyses. Conclusion H. pylori eradication is associated with a signifi cantly lower risk of GC; this fi nding has signifi cant implications for the prevention of this cancer. Th e benefi t is maximized when H. pylori eradication is applied at early stages of the infection

Spanish influenza of 1918–19: the extent and spread in South Australia

“This article is reprinted with permission of the Australasian Epidemiological Association”The 1918–19 Spanish influenza was the first pandemic for which official records were compiled in South Australia. This followed the recognition of the disease as notifiable under the Public Health Act and the establishment of a surveillance system by the then South Australia Central Health Board (a precursor to the current South Australian Health Department). This is the first paper to describe the Spanish influenza epidemic for South Australia from an epidemiological and geographical perspective. Notification numbers were retrieved from the South Australian Central Health Board meeting records. Data were entered into an Excel spreadsheet and Epi™info 7 software to enable a geographical analysis. There were 8,839 influenza notifications: of these, 4,854 (55.0%) originated from metropolitan areas (Attack Rate 9.9 per 1,000 population) and 3,985 notifications (45.0%) originated from regional areas (Attack Rate 8.0 per 1,000 population). There was a lack of comprehensive epidemiological data due to the still developing surveillance system. This restrained more in-depth analysis of risk factors and geological spread

Sex-specific risk factor profile in oesophageal adenocarcinoma

A nationwide Swedish case–control study of 388 men and 63 women with adenocarcinoma of the oesophagus and gastro-oesophageal function and 676 men controls and 140 women investigated whether sex differences in aetiology contribute to male predominance. Compared with men, women seemed more vulnerable to reflux (odds ratio (OR)=4.6, 95% confidence interval (CI)=2.0–10.5 vs OR=3.4, 95% CI=2.5–4.6), obesity (OR=10.3, 95% CI=2.6–42.3 vs OR=5.4, 95% CI=2.6–10.8) and smoking (OR=5.3, 95% CI=2.0–14.1 vs OR=2.8, 95% CI=1.9–4.2), less harmed by low intake of fruit and vegetables (OR=0.9, 95% CI 0.3–2.4 vs OR=1.6, 95% CI=1.1–2.2) and less protected by Helicobacter pylori infection (OR=0.5, 95% CI=0.3–0.8 vs OR=1.6, 95% CI=0.5–5.4)

Assessment of socio-techno-economic factors affecting the market adoption and evolution of 5G networks: Evidence from the 5G-PPP CHARISMA project

5G networks are rapidly becoming the means to accommodate the complex demands of vertical sectors. The European project CHARISMA is aiming to develop a hierarchical, distributed-intelligence 5G architecture, offering low latency, security, and open access as features intrinsic to its design. Finding its place in such a complex landscape consisting of heterogeneous technologies and devices, requires the designers of the CHARISMA and other similar 5G architectures, as well as other related market actors to take into account the multiple technical, economic and social aspects that will affect the deployment and the rate of adoption of 5G networks by the general public. In this paper, a roadmapping activity identifying the key technological and socio-economic issues is performed, so as to help ensure a smooth transition from the legacy to future 5G networks. Based on the fuzzy Analytical Hierarchy Process (AHP) method, a survey of pairwise comparisons has been conducted within the CHARISMA project by 5G technology and deployment experts, with several critical aspects identified and prioritized. The conclusions drawn are expected to be a valuable tool for decision and policy makers as well as for stakeholders

Antibiotic resistance prevalence and trends in patients infected with helicobacter pylori in the period 2013–2020: Results of the european registry on h. pylori management (hp-eureg)

Background: Bacterial antibiotic resistance changes over time depending on multiple factors; therefore, it is essential to monitor the susceptibility trends to reduce the resistance impact on the effectiveness of various treatments. Objective: To conduct a time-trend analysis of Helicobacter pylori resistance to antibiotics in Europe. Methods: The international prospective European Registry on Heli-cobacter pylori Management (Hp-EuReg) collected data on all infected adult patients diagnosed with culture and antimicrobial susceptibility testing positive results that were registered at AEG-REDCap e-CRF until December 2020. Results: Overall, 41,562 patients were included in the Hp-EuReg. Culture and antimicrobial susceptibility testing were performed on gastric biopsies of 3974 (9.5%) patients, of whom 2852 (7%) were naive cases included for analysis. The number of positive cultures decreased by 35% from the period 2013–2016 to 2017–2020. Concerning naïve patients, no antibiotic resistance was found in 48% of the cases. The most frequent resistances were reported against metronidazole (30%), clarithromycin (25%), and levofloxacin (20%), whereas resistances to tetracycline and amoxicillin were below 1%. Dual and triple resistances were found in 13% and 6% of the cases, respectively. A decrease (p < 0.001) in the metronidazole resistance rate was observed between the 2013–2016 (33%) and 2017–2020 (24%) periods. Conclusion: Culture and antimicrobial susceptibility testing for Helicobacter pylori are scarcely performed (<10%) in Europe. In naïve patients, Helicobacter pylori resistance to clarithromycin remained above 15% throughout the period 2013–2020 and resistance to levofloxacin, as well as dual or triple resistances, were high. A progressive decrease in metronidazole resistance was observed